Max Formulations Private Limited

Max Formulations Private Limited - pharma in Nasik, Maharashtra, India. FY 2026 financials and compliance.
CIN U24230MH2003PTC138530 Incorporated 03 January 2003 ROC Mumbai HQ Nasik, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹26 Lakh
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹87.45 Lakh
Company age
23 yrs
Est. 2003
Last financials
Mar 2006
Balance sheet date

About Max Formulations Private Limited

Data last updated: 10 February 2026

Max Formulations Private Limited is a private limited company based in Nasik, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 January 2003, the company has been in operation for over 23 years.

Registered with ROC Mumbai under CIN U24230MH2003PTC138530.

Capital: an authorised share capital of ₹30 Lakh and a paid-up capital of ₹26 Lakh. It is led by directors including Vaibhav Vijay Patil and Dhananjay Rajendra Kale.

Last AGM: 30 September 2006. Financial statements filed for year ended 31 March 2006. Office: B – 24/25 Nice Areasatpur Industrial Area Nasik, Maharashtra, India – 422007.

As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹87.45 Lakh on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Max Formulations Private Limited
CIN U24230MH2003PTC138530
Registration Number 138530
Incorporation Date 03 January 2003
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2006
Date of Balance Sheet 31 March 2006
Compliance Status Active Non-Compliant
Key People
Vaibhav Vijay Patil Director Dhananjay Rajendra Kale Director Kiran Sudhakar Patil Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    B – 24/25 Nice Areasatpur Industrial Area Nasik, Maharashtra, India – 422007
  • Industry
    Pharma, Drug Formulation & Development
Company report
Max Formulations Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Max Formulations Private Limited report

Financials, compliance, directors, charges, ownership and filings for Max Formulations Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Board of Directors of Max Formulations Private Limited

Max Formulations Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Vaibhav Vijay Patil
Also directs: Sunlake Resorts And Hotels Limited, Vijay Capsules Limited, Nasik Guest House Private Limited
Director 03 Jan 2003 23 Years 6 Months Current
Dhananjay Rajendra Kale Director 22 Aug 2006 19 Years 10 Months Current
Kiran Sudhakar Patil Director 02 Apr 2008 18 Years 3 Months Current
View all directors

Financials of Max Formulations Private Limited FY 2006 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Max Formulations Private Limited

Open charges
₹2 Cr
Satisfied charges
₹87.45 Lakh
Breakdown by lending institutions
The Hongkong and Shanghai Banking Corporation₹2.00 Cr
Latest charge details
DateLenderAmountStatus
06 Dec 2007 The Hongkong and Shanghai Banking Corporation ₹2 Cr Open
22 May 2003 Bank of India ₹87.45 Lakh Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Max Formulations Private Limited

View historical data on people associated with Max Formulations Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Max Formulations Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Max Formulations Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Max Formulations Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Max Formulations Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Max Formulations Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Max Formulations Private Limited

MSME Payment Delays by Max Formulations Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Max Formulations Private Limited

Subsidiaries & Group Companies of Max Formulations Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Max Formulations Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Max Formulations Private Limited

MCA Filings & Documents of Max Formulations Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Max Formulations Private Limited

Charges
09 Jan 2009
A charge registered on 22 May 2003 via Charge ID 90148284 with Bank Of India was fully satisfied on 09 Jan 2009.
Directors
02 Apr 2008
Kiran Sudhakar Patil was appointed as a Director on 02 Apr 2008 & has been associated with this company since 18 years 3 months.
Charges
06 Dec 2007
A charge with The Hongkong And Shanghai Banking Corporation amounted to Rs. 200.00 Lakh with Charge ID 10084715 was registered on 06 Dec 2007.
Activity
30 Sep 2006
Max Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2006 as per latest MCA records.
Directors
22 Aug 2006
Dhananjay Rajendra Kale was appointed as a Director on 22 Aug 2006 & has been associated with this company since 19 years 10 months.
Activity
31 Mar 2006
Max Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2006 with Roc Mumbai.

Frequently Asked Questions about Max Formulations Private Limited

Max Formulations Private Limited is an active private limited company in the pharma sector based in Nasik, Maharashtra, India. It was incorporated on 03 January 2003 (23+ years old) and is registered under CIN U24230MH2003PTC138530.

The current directors of Max Formulations Private Limited are:

The primary industry of Max Formulations Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Max Formulations Private Limited can be reached at the registered office: B – 2425 Nice Areasatpur Industrial Area Nasik, Maharashtra, India – 422007.

The authorised capital is ₹30 Lakh, and the paid-up capital is ₹26 Lakh.

The company has its registered office at B – 2425 Nice Areasatpur Industrial Area Nasik, Maharashtra, India – 422007.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available